0 items USD 0.00Search
Your search for "delveinsight non hodgkin lymphoma nhl market insights epidemiology market forecast 2023 7mm" gave back 48388 results.
Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Industry Forecast” looks at past sales and reviews total world B-Cell Non-Hodgkin's...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Highlights The global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global Adult Non-Hodgkin Lymphoma Treatment market size was valued at USD 7820 million in 2022 and is forecast to a readjusted size of USD 13440...
Catalog:
GIR
August 2023
Price: USD 3,480.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Adult Non-Hodgkin Lymphoma Treatment market size is projected to grow from US$ 7434.7 million in 2022 to US$ 13340 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Adult Non-Hodgkin Lymphoma Treatment market size is expected to reach $ 13440 million by 2029, rising at a market growth of 8.0% CAGR...
Catalog:
GIR
August 2023
Price: USD 4,480.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have the ability to spread, they are called malignant. The...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Highlights The global Radioimmunotherapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Rituxan (Rituximab) and Biosimilar market size was valued at USD 4244.4 million in 2022 and is forecast to a readjusted size of USD 5345.4...
Catalog:
GIR
June 2023
Price: USD 3,480.00
